K

KPTI

Karyopharm Therapeutics Inc

9.10

-0.01-0.11%
After Hours: 9.47  +0.37  +4.07%19:59 05/29 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE9.28/9.10
TODAY RANGE8.99-9.88
VOL157.34K
MARKET CAP220.65M
52 WEEK RANGE3.650-10.99
AVG VOL (3M)926.05K
% TURNOVER0.69%
TURNOVER--
P/E (TTM)-0.6559
% RANGE9.78%
EPS(TTM)-14.8444
P/E(FORWARD)-2.3804
P/B-0.8262
BVPS-11.7834
DIVIDEND--
P/S1.221
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP209.04M
SHARES OUTSTANDING22.66M
NEXT EARNINGS08/10-08/14
FREE FLOAT21.47M
LOT SIZE1
EX-DATE02/26/2025
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

麥克森

MCK

-1.92%
742.44

生物基因

BIIB

-0.20%
196.00

安進

AMGN

+0.09%
336.79

沙爾製藥

SHPG

0.00%
179.20

B

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

+0.26%
0.1153

禮來

LLY

-1.93%
--

新基醫藥

CELG

0.00%
108.24

T

Therapeuticsmd Inc

TXMD

+1.42%
2.140

強生

JNJ

-2.37%
225.33

ABBV

--

ZTS

--

吉利德科學

GILD

-1.31%
134.43

N

Novo-Nordisk A/S

NVO

+0.15%
45.58

百時美施貴寶

BMY

+0.47%
57.18

亞力兄製藥

ALXN

+1.70%
182.50

輝瑞製藥

PFE

+0.15%
26.18

賽諾菲

SNY

-1.40%
43.67

S

Sanofi FR

GCVRZ

0.00%
0.8711

諾華製藥

NVS

-0.81%
150.17

D

Dr Reddys Labs

RDY

+0.81%
13.63

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.